Sculptor Capital LP Buys 717,728 Shares of Sotera Health Company $SHC

Sculptor Capital LP lifted its stake in Sotera Health Company (NASDAQ:SHC) by 3.4% during the first quarter, HoldingsChannel reports. The fund owned 21,717,728 shares of the company’s stock after purchasing an additional 717,728 shares during the quarter. Sotera Health comprises approximately 3.3% of Sculptor Capital LP’s holdings, making the stock its 4th biggest position. Sculptor Capital LP owned about 0.08% of Sotera Health worth $311,432,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. IFP Advisors Inc lifted its holdings in shares of Sotera Health by 1,105.6% during the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after buying an additional 1,371 shares during the last quarter. Rothschild Investment LLC bought a new stake in shares of Sotera Health in the 4th quarter valued at approximately $27,000. Root Financial Partners LLC increased its holdings in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after buying an additional 1,455 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new position in Sotera Health during the fourth quarter valued at approximately $40,000. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 15.36% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on SHC shares. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Piper Sandler reaffirmed an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Finally, UBS Group set a $19.00 price objective on shares of Sotera Health in a report on Wednesday, June 24th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.25.

Sotera Health Stock Performance

Shares of NASDAQ:SHC opened at $17.35 on Monday. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The stock’s 50-day moving average is $16.65 and its 200-day moving average is $16.38. The company has a market cap of $4.95 billion, a P/E ratio of 42.32 and a beta of 1.76. Sotera Health Company has a 52-week low of $11.00 and a 52-week high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. During the same quarter in the previous year, the firm earned $0.14 EPS. The firm’s revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities research analysts predict that Sotera Health Company will post 0.87 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.